A phase II trial of neoadjuvant cisplatin (C), gemcitabine (G), and sunitinib (S) in muscle-invasive urothelial carcinoma (miUC): Results from Hoosier Oncology Group GU07-123 trial.
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: S. P. Lerner, T. Powles, N. M. Hahn, T. Gardner, L. Cheng, J. Green, D. Berney, D. Taber, J. Landgraf, S. S. Shen, G. Sonpavde
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2591295891